sec filing
NE
NASDAQ · NEPH
Nephros, Inc.
Healthcare · Medical - Instruments & Supplies
$3.25
Up+$0.01 (+0.31%)
Updated Nov 5, 2026, 4:08 AM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 52.9M
- P/E ratio
- 35.79
- Dividend yield
- 0.00%
- 52-week range
- $2.66 – $4.87
- Volume
- 10.47K
- Avg. volume
- 78.57K
Price performance · NEPH
NEPH price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
NEPH closed at $3.25 after 21 trading sessions, up 1.56% for the selected period.
- Last close
- $3.25
- Period change
- +1.56%
- Period low
- $3.17
- Period high
- $3.68
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $3.28 | $3.30 | $3.20 | $3.25 | 10.47K |
| Nov 3, 2026 | $3.17 | $3.27 | $3.17 | $3.24 | 63.72K |
| Nov 2, 2026 | $3.17 | $3.32 | $3.17 | $3.24 | 58.74K |
| Oct 30, 2026 | $3.38 | $3.50 | $3.17 | $3.17 | 12.42K |
| Oct 29, 2026 | $3.17 | $3.3099 | $3.085 | $3.27 | 72.44K |
| Oct 28, 2026 | $3.52 | $3.52 | $3.09 | $3.17 | 236.02K |
| Oct 27, 2026 | $3.73 | $3.73 | $3.36 | $3.51 | 46.87K |
| Oct 26, 2026 | $3.56 | $3.6995 | $3.53 | $3.63 | 39.09K |
| Oct 23, 2026 | $3.54 | $3.77 | $3.50 | $3.53 | 45.5K |
| Oct 22, 2026 | $3.58 | $3.58 | $3.52 | $3.52 | 4.11K |
| Oct 21, 2026 | $3.58 | $3.71 | $3.51 | $3.59 | 14.21K |
| Oct 20, 2026 | $3.68 | $3.69 | $3.41 | $3.52 | 40.97K |
| Oct 19, 2026 | $3.58 | $3.75 | $3.53 | $3.68 | 47.24K |
| Oct 16, 2026 | $3.45 | $3.65 | $3.39 | $3.65 | 46K |
| Oct 15, 2026 | $3.54 | $3.66 | $3.4115 | $3.51 | 26.23K |
| Oct 14, 2026 | $3.46 | $3.5719 | $3.3301 | $3.52 | 9.2K |
| Oct 13, 2026 | $3.53 | $3.60 | $3.415 | $3.59 | 20.6K |
| Oct 12, 2026 | $3.61 | $3.70 | $3.46 | $3.57 | 67K |
| Oct 9, 2026 | $3.33 | $3.54 | $3.31 | $3.53 | 35.8K |
| Oct 8, 2026 | $3.16 | $3.30 | $3.1055 | $3.29 | 135.66K |
| Oct 7, 2026 | $3.08 | $3.54 | $3.05 | $3.20 | 46.6K |
Latest NEPH news
The latest Smart Investors Daily articles mentioning NEPH.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…